$14.41
-0.04-0.28%
At close: -
$14.41
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Crescent Capital BDC Analyst Ratings and Price Targets | NASDAQ:CCAP | Benzinga
Crescent Capital BDC Inc has a consensus price target of $17.83 based on the ratings of 6 analysts. The high is $20 issued by Ladenburg Thalmann on September 30, 2024. The low is $15 issued by Wells Fargo on May 16, 2025. The 3 most-recent analyst ratings were released by Raymond James, Keefe, Bruyette & Woods, and Wells Fargo on May 16, 2025, respectively. With an average price target of $16.33 between Raymond James, Keefe, Bruyette & Woods, and Wells Fargo, there's an implied 13.35% upside for Crescent Capital BDC Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Keefe, Bruyette & Woods
Wells Fargo
Ladenburg Thalmann
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Crescent Capital BDC
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2025 | Buy Now | 17.97% | Raymond James | Robert Dodd64% | $20 → $17 | Maintains | Outperform | Get Alert |
| 05/16/2025 | Buy Now | 17.97% | Keefe, Bruyette & Woods | Ryan Lynch49% | $18.5 → $17 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/16/2025 | Buy Now | 4.09% | Wells Fargo | Finian O'Shea63% | $16 → $15 | Maintains | Equal-Weight | Get Alert |
| 04/28/2025 | Buy Now | 11.03% | Wells Fargo | Finian O'Shea63% | $18 → $16 | Maintains | Equal-Weight | Get Alert |
| 04/08/2025 | Buy Now | 28.38% | Keefe, Bruyette & Woods | Ryan Lynch49% | $20 → $18.5 | Maintains | Outperform | Get Alert |
| 02/21/2025 | Buy Now | 24.91% | Wells Fargo | Finian O'Shea63% | $19 → $18 | Maintains | Equal-Weight | Get Alert |
| 01/29/2025 | Buy Now | 31.85% | Wells Fargo | Finian O'Shea63% | $18 → $19 | Maintains | Equal-Weight | Get Alert |
| 11/25/2024 | Buy Now | 38.79% | Keefe, Bruyette & Woods | Ryan Lynch49% | $19 → $20 | Maintains | Outperform | Get Alert |
| 09/30/2024 | Buy Now | 38.79% | Ladenburg Thalmann | Mickey Schleien65% | → $20 | Initiates | → Buy | Get Alert |
| 08/15/2024 | Buy Now | 31.85% | B of A Securities | Derek Hewett47% | $20 → $19 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 24.91% | Wells Fargo | Finian O'Shea63% | $19 → $18 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 31.85% | Wells Fargo | Finian O'Shea63% | $18 → $19 | Maintains | Equal-Weight | Get Alert |
| 05/23/2024 | Buy Now | 31.85% | Keefe, Bruyette & Woods | Ryan Lynch49% | $18.5 → $19 | Maintains | Outperform | Get Alert |
| 05/13/2024 | Buy Now | 24.91% | Wells Fargo | Finian O'Shea63% | $16.5 → $18 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 31.85% | Raymond James | Robert Dodd64% | $18 → $19 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 31.85% | Oppenheimer | Mitchel Penn44% | $18 → $19 | Maintains | Outperform | Get Alert |
| 01/29/2024 | Buy Now | 14.5% | Wells Fargo | Finian O'Shea63% | $16 → $16.5 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | Buy Now | 11.03% | Wells Fargo | Finian O'Shea63% | $16.5 → $16 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/16/2023 | Buy Now | 24.91% | Oppenheimer | Mitchel Penn44% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2023 | Buy Now | 24.91% | Keefe, Bruyette & Woods | Ryan Lynch49% | → $18 | Initiates | → Outperform | Get Alert |
| 02/24/2023 | Buy Now | 24.91% | Oppenheimer | Mitchel Penn44% | $19 → $18 | Maintains | Outperform | Get Alert |
| 10/05/2022 | Buy Now | 24.91% | Raymond James | Robert Dodd64% | $20.5 → $18 | Maintains | Outperform | Get Alert |
| 08/12/2022 | Buy Now | 31.85% | Oppenheimer | Mitchel Penn44% | $20 → $19 | Upgrade | Perform → Outperform | Get Alert |
| 08/12/2022 | Buy Now | 42.26% | Raymond James | Robert Dodd64% | $21 → $20.5 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Crescent Capital BDC (CCAP) stock?
The latest price target for Crescent Capital BDC (NASDAQ:CCAP) was reported by Raymond James on May 16, 2025. The analyst firm set a price target for $17.00 expecting CCAP to rise to within 12 months (a possible 17.97% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Crescent Capital BDC (CCAP)?
The latest analyst rating for Crescent Capital BDC (NASDAQ:CCAP) was provided by Raymond James, and Crescent Capital BDC maintained their outperform rating.
When was the last upgrade for Crescent Capital BDC (CCAP)?
The last upgrade for Crescent Capital BDC Inc happened on August 12, 2022 when Oppenheimer raised their price target to $19. Oppenheimer previously had a perform for Crescent Capital BDC Inc.
When was the last downgrade for Crescent Capital BDC (CCAP)?
The last downgrade for Crescent Capital BDC Inc happened on May 16, 2025 when Keefe, Bruyette & Woods changed their price target from $18.5 to $17 for Crescent Capital BDC Inc.
When is the next analyst rating going to be posted or updated for Crescent Capital BDC (CCAP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crescent Capital BDC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crescent Capital BDC was filed on May 16, 2025 so you should expect the next rating to be made available sometime around May 16, 2026.
Is the Analyst Rating Crescent Capital BDC (CCAP) correct?
While ratings are subjective and will change, the latest Crescent Capital BDC (CCAP) rating was a maintained with a price target of $20.00 to $17.00. The current price Crescent Capital BDC (CCAP) is trading at is $14.41, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
